A thin, flexible plastic film covered in billions of microscopic spikes can physically destroy respiratory viruses without chemicals, UV light, or any active coating, according to a peer-reviewed study published in Advanced Science in early 2025. Researchers at RMIT University in Melbourne, Australia, found that the film eliminated roughly 94% of a test virus’s ability to infect cells within one hour, using nothing more than the geometry of its surface.
The concept is deceptively simple. Engineers etched the surface of an ordinary acrylic sheet with nanoscale pillars, each one far too small to see or feel, arranged in tight rows. When a virus lands on the film, those pillars puncture its outer lipid envelope, the same fatty membrane that makes pathogens like influenza, RSV, and coronaviruses infectious. Once that envelope is breached, the virus falls apart.
“The surface uses mechanical force rather than chemical disinfectants,” the RMIT research team wrote in the study, distinguishing their approach from conventional antimicrobial coatings that rely on silver ions, copper alloys, or light-activated catalysts.
If the technology proves durable and broadly effective, it could eventually be applied as a peel-and-stick overlay on hospital door handles, subway handrails, elevator buttons, and other high-touch surfaces where pathogens spread most readily.
How the nanopillars work
The film was tested against human parainfluenza virus type 3 (hPIV-3), an enveloped respiratory pathogen roughly 150 to 200 nanometers in diameter. Under controlled laboratory conditions, viral particles placed on the textured surface lost about 94% of their infectivity within 60 minutes, according to the study’s plaque-reduction assays.
Spacing between the pillars turned out to be the decisive engineering variable. Surfaces with features spaced approximately 60 nanometers apart produced the strongest antiviral effect. At roughly 100 nanometers, performance dropped noticeably. At approximately 200 nanometers, the surface showed effectively no antiviral activity at all. The pattern suggests a straightforward design rule: tighter pillar spacing better matches the dimensions of viral particles, increasing the odds that a virus landing on the surface will be impaled and ruptured.
Because the mechanism is purely physical, the film does not depend on lighting conditions, temperature, or chemical replenishment. That gives it a theoretical advantage over photocatalytic antiviral films described in a 2022 study, which required specific light exposure and used coatings that degraded over time.
Building on earlier nanostructure research
The idea of killing pathogens with surface texture is not new. Scientists have known for years that the wings of cicadas and dragonflies are covered in nanoscale spikes that shred bacteria on contact. Researchers have been trying to replicate that effect synthetically, mostly targeting bacteria rather than viruses.
A 2023 study published in ACS Nano demonstrated that nanostructured surfaces with sharp spikes could pierce hPIV-3 and measurably reduce its infectivity over several hours. Separate work published in ACS Biomaterials Science & Engineering showed that nanostructured metal surfaces designed for hospital environments also reduced recoverable viable virus.
What the RMIT study adds is a practical substrate. Earlier mechano-virucidal experiments often used rigid materials like silicon or titanium. Acrylic film is cheap, lightweight, and flexible enough to conform to curved or irregular surfaces. If the nanopatterning process can be integrated into existing plastic manufacturing lines, the researchers suggest, the technology could scale far more easily than metal-based alternatives.
What the study did not test
For all its promise, the research has significant gaps that will need to be closed before the film moves beyond the laboratory.
Only one virus was tested. hPIV-3 is an enveloped pathogen, meaning it has the lipid membrane that the nanopillars are designed to rupture. Non-enveloped viruses, such as norovirus and rhinovirus, lack that membrane and tend to be more mechanically robust. Whether the same surface geometry would damage a protein capsid is an open question. The research team has indicated that testing against a broader panel of viruses, including smaller pathogens, is planned, but no results from those experiments have been published as of May 2026.
Real-world durability is another unknown. The study measured viral inactivation on clean surfaces under controlled conditions. On a hospital handrail or a subway turnstile, the nanopillars would face contamination from skin oils, dust, cleaning agents, and dried organic debris. Even a thin residue layer could shield viruses from direct contact with the spikes. No published data yet address how the film performs after weeks of use, repeated cleaning, or environmental exposure.
Mechanical wear is a related concern. Acrylic can scratch, craze, or lose clarity over time, especially when wiped with abrasive cleaners. If routine maintenance wears down or fractures the nanopillars, the antiviral effect could degrade well before the plastic itself fails. The study does not include accelerated aging tests, abrasion resistance data, or cost projections for industrial-scale production.
Where this fits in infection control
Antimicrobial surfaces already exist in hospitals and transit systems. Copper alloys, for instance, have well-documented ability to kill bacteria and some viruses within hours, and copper-infused touch surfaces have been installed in intensive care units around the world. But copper is expensive, heavy, and difficult to retrofit onto existing infrastructure. Silver-ion coatings and chemical disinfectant films face their own limitations: cost, toxicity concerns, and the need for periodic reapplication.
A cheap, flexible, chemical-free plastic overlay would fill a different niche. It would not replace hand hygiene, ventilation, or routine cleaning, but it could add a passive layer of protection on surfaces that are touched hundreds of times a day between cleanings. The appeal is in the simplicity: a film that works around the clock, in any lighting, without batteries or refills.
That appeal, however, rests on assumptions that have not yet been validated outside a single laboratory study. Broad-spectrum antiviral activity, long-term durability under realistic conditions, and cost-effective manufacturing all remain to be demonstrated. The 94% infectivity reduction against hPIV-3 is a strong proof of concept, and the underlying science aligns with a growing body of nanostructure research. But one virus on one substrate in one lab is the starting line, not the finish.
What comes next for mechano-virucidal plastic films
For now, the RMIT film is best understood as a materials engineering advance that opens a promising new direction, not a product ready for deployment. The next round of studies, testing more pathogens, simulating real-world wear, and estimating production costs, will determine whether textured plastic films become a practical tool in the long-running effort to make shared surfaces safer.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
